PHARMACEUTICAL COMPOSITION COMPRISING (1S)-1,5-ANHYDRO-1-[5-(4-ETHOXYBENZYL)-2-METOXY-4-METHYLPHENYL]-1-THIO-D-GLUCITOL AND METFORMIN AND USES THEREOF IN THE TREATMENT OF DIABETES
A pharmaceutical composition comprising a combination of (A) (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol and (B) at least one member of the group consisting of insulin secretagogues, insulin sensitizers, insulins, dipeptidyl peptidase IV inhibitors, ±-glucosidase inhibitors, and GLP-1 mimetics, has superior efficacy in preventing or treating diabetes mellitus, diseases associated with diabetes mellitus, or complications of diabetes mellitus and yet it causes no appreciable side effects.Farmaceutski preparat naznačen time što sadrži kombinaciju:(A) (1S)-1,5-anhidro-1 -[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1 -tio-D-glucitola ili njegove farmaceutski prihvatljive soli ili hidrata takvog jedinjenja ili takve soli； i(B) metformina.Prijava sadrži još 5 patentnih zahteva.
